FDA Inspection 1192256 — Centaur Pharmaceuticals Private Ltd.
The FDA completed an inspection of Centaur Pharmaceuticals Private Ltd. on Nov 21, 2022 in Thane. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Nov 21, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Thane (India)